These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2059 related articles for article (PubMed ID: 11698225)

  • 1. The biology of human natural killer-cell subsets.
    Cooper MA; Fehniger TA; Caligiuri MA
    Trends Immunol; 2001 Nov; 22(11):633-40. PubMed ID: 11698225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells.
    Juelke K; Killig M; Luetke-Eversloh M; Parente E; Gruen J; Morandi B; Ferlazzo G; Thiel A; Schmitt-Knosalla I; Romagnani C
    Blood; 2010 Aug; 116(8):1299-307. PubMed ID: 20505160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New miRNA Signature Heralds Human NK Cell Subsets at Different Maturation Steps: Involvement of miR-146a-5p in the Regulation of KIR Expression.
    Pesce S; Squillario M; Greppi M; Loiacono F; Moretta L; Moretta A; Sivori S; Castagnola P; Barla A; Candiani S; Marcenaro E
    Front Immunol; 2018; 9():2360. PubMed ID: 30374356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of chemokines in the biology of natural killer cells.
    Maghazachi AA
    Curr Top Microbiol Immunol; 2010; 341():37-58. PubMed ID: 20369317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56
    Euchner J; Sprissler J; Cathomen T; Fürst D; Schrezenmeier H; Debatin KM; Schwarz K; Felgentreff K
    Front Immunol; 2021; 12():640672. PubMed ID: 34017328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD56
    Vujanovic L; Chuckran C; Lin Y; Ding F; Sander CA; Santos PM; Lohr J; Mashadi-Hossein A; Warren S; White A; Huang A; Kirkwood JM; Butterfield LH
    Front Immunol; 2019; 10():14. PubMed ID: 30761123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts.
    Chan A; Hong DL; Atzberger A; Kollnberger S; Filer AD; Buckley CD; McMichael A; Enver T; Bowness P
    J Immunol; 2007 Jul; 179(1):89-94. PubMed ID: 17579025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin.
    Batoni G; Esin S; Favilli F; Pardini M; Bottai D; Maisetta G; Florio W; Campa M
    Scand J Immunol; 2005 Dec; 62(6):498-506. PubMed ID: 16316416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel insights on human NK cells' immunological modalities revealed by gene expression profiling.
    Hanna J; Bechtel P; Zhai Y; Youssef F; McLachlan K; Mandelboim O
    J Immunol; 2004 Dec; 173(11):6547-63. PubMed ID: 15557145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for NK cell subsets based on chemokine receptor expression.
    Berahovich RD; Lai NL; Wei Z; Lanier LL; Schall TJ
    J Immunol; 2006 Dec; 177(11):7833-40. PubMed ID: 17114454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56
    Veneziani I; Alicata C; Pelosi A; Landolina N; Ricci B; D'Oria V; Fagotti A; Scambia G; Moretta L; Maggi E
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35091452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Killer Ig-like receptor (KIR) genotype predicts the capacity of human KIR-positive CD56dim NK cells to respond to pathogen-associated signals.
    Korbel DS; Norman PJ; Newman KC; Horowitz A; Gendzekhadze K; Parham P; Riley EM
    J Immunol; 2009 May; 182(10):6426-34. PubMed ID: 19414796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD16- CD56+ natural killer cells after bone marrow transplantation.
    Jacobs R; Stoll M; Stratmann G; Leo R; Link H; Schmidt RE
    Blood; 1992 Jun; 79(12):3239-44. PubMed ID: 1375847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential alteration of CD56(bright) and CD56 (dim) natural killer cells in frequency, phenotype, and cytokine response in chronic hepatitis C virus infection.
    Miyagi T; Shimizu S; Tatsumi T; Nishio K; Hiramatsu N; Kanto T; Hayashi N; Takehara T
    J Gastroenterol; 2011 Aug; 46(8):1020-30. PubMed ID: 21559771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets.
    Yu J; Mao HC; Wei M; Hughes T; Zhang J; Park IK; Liu S; McClory S; Marcucci G; Trotta R; Caligiuri MA
    Blood; 2010 Jan; 115(2):274-81. PubMed ID: 19897577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL15 Infusion of Cancer Patients Expands the Subpopulation of Cytotoxic CD56
    Dubois S; Conlon KC; Müller JR; Hsu-Albert J; Beltran N; Bryant BR; Waldmann TA
    Cancer Immunol Res; 2017 Oct; 5(10):929-938. PubMed ID: 28842470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD56bright natural killer (NK) cells: an important NK cell subset.
    Poli A; Michel T; Thérésine M; Andrès E; Hentges F; Zimmer J
    Immunology; 2009 Apr; 126(4):458-65. PubMed ID: 19278419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analyses of phenotypic and functional characteristics of CX3CR1-expressing natural killer cells.
    Hamann I; Unterwalder N; Cardona AE; Meisel C; Zipp F; Ransohoff RM; Infante-Duarte C
    Immunology; 2011 May; 133(1):62-73. PubMed ID: 21320123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation.
    Dulphy N; Haas P; Busson M; Belhadj S; Peffault de Latour R; Robin M; Carmagnat M; Loiseau P; Tamouza R; Scieux C; Rabian C; Di Santo JP; Charron D; Janin A; Socié G; Toubert A
    J Immunol; 2008 Aug; 181(3):2227-37. PubMed ID: 18641363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific phenotype and function of CD56-expressing innate immune cell subsets in human thymus.
    Gerstner S; Köhler W; Heidkamp G; Purbojo A; Uchida S; Ekici AB; Heger L; Luetke-Eversloh M; Schubert R; Bader P; Klingebiel T; Koehl U; Mackensen A; Romagnani C; Cesnjevar R; Dudziak D; Ullrich E
    J Leukoc Biol; 2016 Dec; 100(6):1297-1310. PubMed ID: 27354408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 103.